top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Microbial genomics
Microbial genomics
Pubbl/distr/stampa [London] : , : Society for General Microbiology, , 2015-
Descrizione fisica 1 online resource
Disciplina 579.3135
Soggetto topico Microbial genomics
Genomics
Genome, Microbial
Soggetto genere / forma Periodicals.
Periodical
Fulltext
Internet Resources.
ISSN 2057-5858
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Nota di contenuto Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population -- Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study -- Prevalence of HCV genotypes in Poland - the EpiTer study -- Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases -- The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin -- The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation.
Altri titoli varianti MGen
Record Nr. UNINA-9910168759903321
[London] : , : Society for General Microbiology, , 2015-
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Microbial genomics
Microbial genomics
Pubbl/distr/stampa [London] : , : Society for General Microbiology, , 2015-
Descrizione fisica 1 online resource
Disciplina 579.3135
Soggetto topico Microbial genomics
Genomics
Genome, Microbial
Soggetto genere / forma Periodicals.
Periodical
Fulltext
Internet Resources.
ISSN 2057-5858
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Nota di contenuto Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population -- Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study -- Prevalence of HCV genotypes in Poland - the EpiTer study -- Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases -- The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin -- The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation.
Altri titoli varianti MGen
Record Nr. UNISA-996222948903316
[London] : , : Society for General Microbiology, , 2015-
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui